Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients

Computational Study of Potential Galectin-3 Inhibitors in the Treatment of COVID-19

(2021) Maral Aminpour et al.   Biomedicines

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

(2020) Chih-Cheng Lai et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases

(2020) Akira Hara et al.   Biomolecules

Prognostic value of C-reactive protein in patients with COVID-19

(2020) Xiaomin Luo et al.   CLINICAL INFECTIOUS DISEASES

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

(2020) Mingfeng Liao et al.   NATURE MEDICINE

Cytokine release syndrome in severe COVID-19

(2020) John B. Moore et al.   SCIENCE

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

(2020) Chaomin Wu et al.   JAMA Internal Medicine

Pulmonary fibrosis secondary to COVID-19: a call to arms?

(2020) Paolo Spagnolo et al.   Lancet Respiratory Medicine

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

(2020) Peter M George et al.   Lancet Respiratory Medicine

Cytokine storm and leukocyte changes in mild versus severe SARS‐CoV‐2 infection: Review of 3939 COVID‐19 patients in China and emerging pathogenesis and therapy concepts

(2020) Jin Wang et al.   JOURNAL OF LEUKOCYTE BIOLOGY

C-reactive protein levels in the early stage of COVID-19

(2020) L. Wang   MEDECINE ET MALADIES INFECTIEUSES

Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases

(2020) Wei Huang et al.   Science China-Life Sciences

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia

(2020) Sara De Biasi et al.   Nature Communications

An inflammatory cytokine signature predicts COVID-19 severity and survival

(2020) Diane Marie Del Valle et al.   NATURE MEDICINE

T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis

(2020) Bahire Kalfaoglu et al.   Frontiers in Immunology

Target-inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis

(2020) Nikhil Hirani et al.   EUROPEAN RESPIRATORY JOURNAL

Early improvements in pulmonary function after severe COVID-19 requiring mechanical ventilation

(2020) Barbara Bonnesen et al.   Infectious Diseases

Galectin-3 Enhances Avian H5N1 Influenza A Virus–Induced Pulmonary Inflammation by Promoting NLRP3 Inflammasome Activation

(2018) Yu-Jung Chen et al.   AMERICAN JOURNAL OF PATHOLOGY

The Predictive Value of Plasma Galectin-3 for Ards Severity and Clinical Outcome

(2017) Zhiheng Xu et al.   SHOCK

Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

(2015) Jonas Christian Schupp et al.   PLoS One

Mechanical Ventilation–associated Lung Fibrosis in Acute Respiratory Distress Syndrome

(2014) Nuria E. Cabrera-Benitez et al.   ANESTHESIOLOGY

IL-6 in Inflammation, Immunity, and Disease

(2014) T. Tanaka et al.   Cold Spring Harbor Perspectives in Biology

The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance

(2013) E. L. Burnham et al.   EUROPEAN RESPIRATORY JOURNAL

Galectin-3 Functions as an Alarmin: Pathogenic Role for Sepsis Development in Murine Respiratory Tularemia

(2013) Bibhuti B. Mishra et al.   PLoS One

Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3

(2011) Alison C. MacKinnon et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The fibrosis marker galectin-3 and outcome in the general population

(2011) R. A. de Boer et al.   JOURNAL OF INTERNAL MEDICINE

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

(2010) Dirk J. A. Lok et al.   Clinical Research in Cardiology

Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways

(2009) Andrew Filer et al.   ARTHRITIS AND RHEUMATISM

The regulation of inflammation by galectin-3

(2009) Neil C. Henderson et al.   IMMUNOLOGICAL REVIEWS